These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 9598903

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
    Anderson JJ, Wells G, Verhoeven AC, Felson DT.
    Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
    [Abstract] [Full Text] [Related]

  • 4. Preliminary definition of disease flare in juvenile rheumatoid arthritis.
    Brunner HI, Lovell DJ, Finck BK, Giannini EH.
    J Rheumatol; 2002 May; 29(5):1058-64. PubMed ID: 12022323
    [Abstract] [Full Text] [Related]

  • 5. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T, Amara I, Koch GG.
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria.
    Arthritis Rheum; 2007 Mar 15; 57(2):193-202. PubMed ID: 17330293
    [Abstract] [Full Text] [Related]

  • 8. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I.
    Arthritis Rheum; 2000 Aug 15; 43(8):1849-57. PubMed ID: 10943876
    [Abstract] [Full Text] [Related]

  • 9. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan 15; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 10. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    Brewer EJ, Giannini EH, Kuzmina N, Alekseev L.
    N Engl J Med; 1986 May 15; 314(20):1269-76. PubMed ID: 3517643
    [Abstract] [Full Text] [Related]

  • 11. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ, Bolognese JA, Felson DT.
    Arthritis Rheum; 2003 Nov 15; 48(11):3031-8. PubMed ID: 14613263
    [Abstract] [Full Text] [Related]

  • 12. Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis.
    Graham TB, Laor T, Dardzinski BJ.
    J Rheumatol; 2005 Sep 15; 32(9):1811-20. PubMed ID: 16142882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
    Arthritis Rheum; 2002 Aug 15; 46(8):2020-8. PubMed ID: 12209503
    [Abstract] [Full Text] [Related]

  • 15. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct 15; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2007 Sep 15; 56(9):3096-106. PubMed ID: 17763439
    [Abstract] [Full Text] [Related]

  • 18. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb 15; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.